BeyondSpring is trading 13.93% lower at $0.58, with no identified company-specific catalyst; broader market weakness provides context. - No company-specific announcement explaining the November 5, 2026, decline surfaced in available search results; the latest identified company news was from September. - Reuters reported steep technology-share losses and broader market weakness on November 5; supplied context showed major indexes and biotech lower. - Shares gained 9.34% on November 4 after falling 22.94% on November 3; evidence does not establish a company-specific cause.